These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 38389324)
1. Distinct phenotype of SARS-CoV-2 Omicron BA.1 in human primary cells but no increased host range in cell lines of putative mammalian reservoir species. Essaidi-Laziosi M; Pérez-Rodríguez FJ; Alvarez C; Sattonnet-Roche P; Torriani G; Bekliz M; Adea K; Lenk M; Suliman T; Preiser W; Müller MA; Drosten C; Kaiser L; Eckerle I Virus Res; 2024 Jan; 339():199255. PubMed ID: 38389324 [TBL] [Abstract][Full Text] [Related]
2. Comparison of SARS-CoV-2 variants of concern in primary human nasal cultures demonstrates Delta as most cytopathic and Omicron as fastest replicating. Tanneti NS; Patel AK; Tan LH; Marques AD; Perera RAPM; Sherrill-Mix S; Kelly BJ; Renner DM; Collman RG; Rodino K; Lee C; Bushman FD; Cohen NA; Weiss SR mBio; 2024 Apr; 15(4):e0312923. PubMed ID: 38477472 [TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 Variants of Concern Hijack IFITM2 for Efficient Replication in Human Lung Cells. Nchioua R; Schundner A; Kmiec D; Prelli Bozzo C; Zech F; Koepke L; Graf A; Krebs S; Blum H; Frick M; Sparrer KMJ; Kirchhoff F J Virol; 2022 Jun; 96(11):e0059422. PubMed ID: 35543509 [TBL] [Abstract][Full Text] [Related]
4. The Omicron Variant BA.1.1 Presents a Lower Pathogenicity than B.1 D614G and Delta Variants in a Feline Model of SARS-CoV-2 Infection. Martins M; do Nascimento GM; Nooruzzaman M; Yuan F; Chen C; Caserta LC; Miller AD; Whittaker GR; Fang Y; Diel DG J Virol; 2022 Sep; 96(17):e0096122. PubMed ID: 36000850 [TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 nonstructural protein 6 from Alpha to Omicron: evolution of a transmembrane protein. Feng S; O'Brien A; Chen DY; Saeed M; Baker SC mBio; 2023 Aug; 14(4):e0068823. PubMed ID: 37477426 [TBL] [Abstract][Full Text] [Related]
6. Automated antigen assays display a high heterogeneity for the detection of SARS-CoV-2 variants of concern, including several Omicron sublineages. Osterman A; Krenn F; Iglhaut M; Badell I; Lehner A; Späth PM; Stern M; Both H; Bender S; Muenchhoff M; Graf A; Krebs S; Blum H; Grimmer T; Durner J; Czibere L; Dächert C; Grzimek-Koschewa N; Protzer U; Kaderali L; Baldauf HM; Keppler OT Med Microbiol Immunol; 2023 Oct; 212(5):307-322. PubMed ID: 37561226 [TBL] [Abstract][Full Text] [Related]
7. The Biological Functions and Clinical Significance of SARS-CoV-2 Variants of Corcern. Akkız H Front Med (Lausanne); 2022; 9():849217. PubMed ID: 35669924 [TBL] [Abstract][Full Text] [Related]
8. Neutralization capacity of antibodies elicited through homologous or heterologous infection or vaccination against SARS-CoV-2 VOCs. Bekliz M; Adea K; Vetter P; Eberhardt CS; Hosszu-Fellous K; Vu DL; Puhach O; Essaidi-Laziosi M; Waldvogel-Abramowski S; Stephan C; L'Huillier AG; Siegrist CA; Didierlaurent AM; Kaiser L; Meyer B; Eckerle I Nat Commun; 2022 Jul; 13(1):3840. PubMed ID: 35787633 [TBL] [Abstract][Full Text] [Related]
9. Modelling the viral dynamics of the SARS-CoV-2 Delta and Omicron variants in different cell types. McCormack CP; Yan AWC; Brown JC; Sukhova K; Peacock TP; Barclay WS; Dorigatti I J R Soc Interface; 2023 Aug; 20(205):20230187. PubMed ID: 37553993 [TBL] [Abstract][Full Text] [Related]
10. Analysis of SARS-CoV-2 in Nasopharyngeal Samples from Patients with COVID-19 Illustrates Population Variation and Diverse Phenotypes, Placing the Growth Properties of Variants of Concern in Context with Other Lineages. Prince T; Dong X; Penrice-Randal R; Randle N; Hartley C; Goldswain H; Jones B; Semple MG; Baillie JK; Openshaw PJM; Turtle L; Hughes GL; Anderson ER; Patterson EI; Druce J; Screaton G; Carroll MW; Stewart JP; Hiscox JA mSphere; 2022 Jun; 7(3):e0091321. PubMed ID: 35491827 [TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 variants Alpha, Beta, Delta and Omicron show a slower host cell interferon response compared to an early pandemic variant. Laine L; Skön M; Väisänen E; Julkunen I; Österlund P Front Immunol; 2022; 13():1016108. PubMed ID: 36248817 [TBL] [Abstract][Full Text] [Related]
12. Experimental co-infection of calves with SARS-CoV-2 Delta and Omicron variants of concern. Cool K; Gaudreault NN; Trujillo JD; Morozov I; McDowell CD; Bold D; Kwon T; Balaraman V; Assato P; Madden DW; Mantlo E; Souza-Neto J; Matias-Ferreyra F; Retallick J; Singh G; Schotsaert M; Carossino M; Balasuriya UBR; Wilson WC; Pogranichniy RM; García-Sastre A; Richt JA Emerg Microbes Infect; 2024 Dec; 13(1):2281356. PubMed ID: 37938158 [TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 Variants Show Different Host Cell Proteome Profiles With Delayed Immune Response Activation in Omicron-Infected Cells. Metzler M; Tharyan RG; Klann K; Grikscheit K; Bojkova D; Cinatl J; Tascher G; Ciesek S; Münch C Mol Cell Proteomics; 2023 May; 22(5):100537. PubMed ID: 37001587 [TBL] [Abstract][Full Text] [Related]
14. Reduced replication but increased interferon resistance of SARS-CoV-2 Omicron BA.1. Nchioua R; Schundner A; Klute S; Koepke L; Hirschenberger M; Noettger S; Fois G; Zech F; Graf A; Krebs S; Braubach P; Blum H; Stenger S; Kmiec D; Frick M; Kirchhoff F; Sparrer KM Life Sci Alliance; 2023 Jun; 6(6):. PubMed ID: 36977594 [TBL] [Abstract][Full Text] [Related]
15. Comparison of SARS-CoV-2 variants of concern in primary human nasal cultures demonstrates Delta as most cytopathic and Omicron as fastest replicating. Tanneti NS; Patel AK; Tan LH; Marques AD; Perera RAPM; Sherrill-Mix S; Kelly BJ; Renner DM; Collman RG; Rodino K; Lee C; Bushman FD; Cohen NA; Weiss SR bioRxiv; 2023 Dec; ():. PubMed ID: 37662273 [TBL] [Abstract][Full Text] [Related]
16. Ancestral Lineage of SARS-CoV-2 Is More Stable in Human Biological Fluids than Alpha, Beta, and Omicron Variants of Concern. Kwon T; Gaudreault NN; Meekins DA; McDowell CD; Cool K; Richt JA Microbiol Spectr; 2023 Feb; 11(1):e0330122. PubMed ID: 36688691 [TBL] [Abstract][Full Text] [Related]
17. Discovery of lead natural products for developing pan-SARS-CoV-2 therapeutics. Pérez-Vargas J; Shapira T; Olmstead AD; Villanueva I; Thompson CAH; Ennis S; Gao G; De Guzman J; Williams DE; Wang M; Chin A; Bautista-Sánchez D; Agafitei O; Levett P; Xie X; Nuzzo G; Freire VF; Quintana-Bulla JI; Bernardi DI; Gubiani JR; Suthiphasilp V; Raksat A; Meesakul P; Polbuppha I; Cheenpracha S; Jaidee W; Kanokmedhakul K; Yenjai C; Chaiyosang B; Teles HL; Manzo E; Fontana A; Leduc R; Boudreault PL; Berlinck RGS; Laphookhieo S; Kanokmedhakul S; Tietjen I; Cherkasov A; Krajden M; Nabi IR; Niikura M; Shi PY; Andersen RJ; Jean F Antiviral Res; 2023 Jan; 209():105484. PubMed ID: 36503013 [TBL] [Abstract][Full Text] [Related]
18. The SARS-CoV-2 Spike is a virulence determinant and plays a major role on the attenuated phenotype of Omicron virus in a feline model of infection. Martins M; Nooruzzaman M; Cunningham JL; Ye C; Caserta LC; Jackson N; Martinez-Sobrido L; Fang Y; Diel DG J Virol; 2024 Mar; 98(3):e0190223. PubMed ID: 38421180 [TBL] [Abstract][Full Text] [Related]
19. Differences in environmental stability among SARS-CoV-2 variants of concern: both omicron BA.1 and BA.2 have higher stability. Hirose R; Itoh Y; Ikegaya H; Miyazaki H; Watanabe N; Yoshida T; Bandou R; Daidoji T; Nakaya T Clin Microbiol Infect; 2022 Nov; 28(11):1486-1491. PubMed ID: 35640841 [TBL] [Abstract][Full Text] [Related]